(Press-News.org) Bethesda, MD (May 14, 2021) -- Combining minimally invasive endoscopic sleeve gastroplasty (ESG) with the diabetes drug semaglutide can provide additional significant weight loss for patients who are not candidates for invasive weight-loss surgery, according to research that was selected for presentation at Digestive Disease Week® (DDW) 2021.
"As the worldwide obesity rate continues to climb, so do the number of people seeking bariatric surgery to treat their condition," said Anna Carolina Hoff, MD, lead researcher on the study and founder and clinical director of Angioskope Brazil, São José dos Campos. "Surgical procedures are some of the most successful ways to help patients lose weight, but they can eventually come with complications. Our study shows that patients may not have to undergo invasive surgery to get similar results."
In a double-blind study, researchers randomized 61 patients undergoing ESG into two groups with one group of 29 patients receiving semaglutide -- an injectable glucagon-like peptide-1 receptor that has been known to stimulate weight loss -- beginning one month after the procedure. Another group of 29 patients received a placebo administered with look-alike injector pens. Three patients were lost to follow-up. Participants were monitored each month for body weight and body composition, and blood panels were taken every three months.
Patients who received semaglutide lost on average 26.7 percent of their total body weight compared to the control group, which on average lost 19.6 percent of total body weight. The semaglutide group lost 86.3 percent of their excess weight -- the amount of weight the patients needed to lose to reach normal BMI -- compared to 60.4 percent for the control group. The semaglutide group also lost 12.7 percent of their body fat by weight compared to 9 percent for the control group. Finally, glycated hemoglobin (Hb1Ac) levels fell 0.95 for the semaglutide group and 0.61 for the controls.
Surgical procedures, such as laparoscopic sleeve gastrectomy, come with increased costs and a higher risk for complications, such as gastroesophageal reflux disease, or GERD. These surgical procedures are typically limited to those with a BMI of at least 35 with comorbidities, or with a BMI above 40. ESG can be performed at an earlier stage of the disease and at a lower BMI, so more patients can get the treatment they need before their disease progresses. Treating patients with obesity earlier can help reduce death and comorbidities as well as reduce costs associated with treatments for these conditions.
"ESG has been available to patients for years, but it has not always been as successful as surgical options in helping patients lose weight," said Dr. Hoff. "We now have a minimally invasive procedure that can be just as successful when combined with semaglutide and can be made available to even more people looking to lose a significant amount of weight."
ESG is performed by guiding a device through the patient's throat and into the stomach, where an endoscopist uses sutures to make the stomach smaller. This helps patients lose weight by limiting the amount they can eat. Patients are candidates for ESG if they have a BMI at or above 30, and diet and exercise have not helped them lose weight, or if they are not a candidate for surgery, or do not wish to pursue surgery.
The researchers caution that long term durability of the treatment still needs to be determined.
DDW Presentation Details
Dr. Hoff will present data from the study, "Semaglutide in association to endoscopic sleeve gastroplasty: Taking endoscopic bariatric procedures outcomes to the next level," abstract Su548, on Sunday, May 23, at 12:15 p.m. EDT. For more information about featured studies, as well as a schedule of availability for featured researchers, please visit http://www.ddw.org/press.
INFORMATION:
Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW is a fully virtual meeting from May 21-23, 2021. The meeting showcases more than 2,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at http://www.ddw.org.
Bethesda, MD (May 14, 2021) -- Inpatient consults for alcohol-related gastrointestinal (GI) and liver diseases have surged since the beginning of the COVID-19 pandemic and remained elevated, according to research selected for presentation at Digestive Disease Week® (DDW) 2021. The proportion of patients that required inpatient endoscopic interventions for their alcohol-related GI and liver diseases has also increased, highlighting an apparent worsening trend in the severity of disease.
"When we went into lockdown, many people experienced significant negative ...
Monash University researchers have validated a way to successfully detect a diverse range of bacteria (pathogens) that cause diarrhoeal disease in informal settlements.
Better protection from disease for people living in communities facing water, sanitation and hygiene challenges is essential, as microbes that cause gastrointestinal disease (enteropathogens) are responsible for 1.4 million deaths per year, predominantly in children under five, and cause impaired nutrition and development.
However, it is highly challenging to effectively monitor their spread due to the sheer number of pathogens and sources involved. Numerous enteropathogens cause diarrhoea and other gastrointestinal diseases, spanning viruses, bacteria, amoeba, and worms, each with distinct characteristics. Moreover, ...
Researchers from Monash University, Queensland University of Technology, and Capital University of Economics and Business published a new paper in the Journal of Marketing that examines the effects of imaginative product displays in retail stores on customers' purchase behavior.
The study, forthcoming in the Journal of Marketing, is titled "Gimmicky or Effective? The Effects of Imaginative Displays on Customers' Purchase Behavior" and is authored by Hean Tat Keh, Di Wang, and Li Yan.
Imaginative displays are constructed using multiple units of the same product in a novel, yet aesthetically appealing, form. Results from six ...
People with healthier heart structure and function appear to have better cognitive abilities, including increased capacity to solve logic problems and faster reaction times, according to research led by Queen Mary University of London and the Radcliffe Department of Medicine at University of Oxford.
Dr Zahra Raisi-Estabragh, BHF Clinical Research Training Fellow at Queen Mary University of London said: "Heart disease and dementia are important and growing public health problems, particularly in ageing populations.
"We already knew that patients with heart disease were more likely to have dementia, and vice versa, but we've now shown that these links between heart and brain health are also present in healthy people. We demonstrated for the ...
Sophia Antipolis, 14 May 2021: Nearly one in four patients with heart failure is depressed or anxious, according to a study published during this week's Heart Failure Awareness Days. Patients with heart failure were 20% more likely to develop these mental health issues during the five years after diagnosis compared to those with cancer. The findings are published in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).1
"The treatment of mental illnesses in cancer patients - psycho-oncology - is long-established but similar services ...
Higher levels of ozone from air pollution are linked to an increased risk of developing fibroids among Black American women according to a large study published today (Friday) in Human Reproduction [1], one of the world's leading reproductive medicine journals.
Fibroids are non-cancerous growths that develop in and around the womb. They are diagnosed in 25-30% of pre-menopausal women, but the true incidence is thought to be between 70-80%. Many fibroids do not cause symptoms but when they do, they are one of the main reasons women are admitted to hospital for inpatient care. Symptoms can include heavy or painful periods, stomach and back pain, constipation, frequent need to urinate, and pain or discomfort during sex. In some ...
The need to evacuate an intensive care unit (ICU) or operating theatre complex during a fire or other emergency is a rare event but one potentially fraught with difficulty: not only is there a risk that patients may come to significant harm but also that staff may be injured and unable to work.
Therefore, the Association of Anaesthetists and the Intensive Care Society are today publishing new 2021 guidelines regarding fire safety and emergency evacuation of ICUs and operating theatres in Anaesthesia (a journal of the Association of Anaesthetists).
These guidelines ...
LA JOLLA, CA--A family of proteins that sense mechanical force--and enable our sense of touch and many other important bodily functions--also are essential for proper root growth in some plants, according to a study led by scientists at Scripps Research and Howard Hughes Medical Institute (HHMI).
The discovery, published in the END ...
According to data from a cohort of adult and pediatric patients with antibody deficiencies, patients that often fail to make protective immune responses to infections and vaccinations showed robust T-cell activity and humoral immunity against SARS-CoV-2 structural proteins. The new study, led by researchers at Children's National Hospital, is the first to demonstrate a robust T-cell response against SARS-CoV-2 in immunocompromised patients.
"If T-cell responses to SARS-CoV-2 are indeed protective, then it could suggest that adoptive T-cell immunotherapy might benefit more profoundly immunocompromised patients," said Michael Keller, M.D., director of the Translational Research Laboratory in the ...
Scientists at the Skolkovo Institute of Science and Technology (Skoltech) and their colleagues from the University of Graz & the Kanzelhöhe Observatory (Austria) and the ESA European Space Operations Centre developed a method and software called RESONANCE to predict the solar radio flux activity for 1-24 months ahead. RESONANCE will serve to improve the specification of satellite orbits, re-entry services, modeling of space debris evolution, and collision avoidance maneuvers. The research results were published in the high-profile Astrophysical Journal Supplement Series.
Since the launch of Sputnik, the Earth's first artificial satellite, in ...
